MF-766 is a highly potent and selective oral EP4 receptor antagonist with sub-nanomolar affinity (Ki = 0.23 nM). It demonstrates full antagonistic activity in functional assays and is a valuable research tool for studying cancer and inflammatory diseases in both in vitro and in vivo models.